| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | AAN7QOV9EA |
| InChI Key | JAZBEHYOTPTENJ-JLNKQSITSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H30O2 |
| Molecular Weight | 302.46 |
| AlogP | 5.99 |
| Hydrogen Bond Acceptor | 1.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 13.0 |
| Polar Surface Area | 37.3 |
| Molecular species | ACID |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 22.0 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Depressive Disorder | 3 | D003866 | ClinicalTrials |
| Arthritis, Rheumatoid | 3 | D001172 | ClinicalTrials |
| Hypertriglyceridemia | 3 | D015228 | ClinicalTrials |
| Coronary Disease | 3 | D003327 | ClinicalTrials |
| Adenomatous Polyposis Coli | 3 | D011125 | ClinicalTrials |
| Heart Failure | 3 | D006333 | ClinicalTrials |
| Depressive Disorder, Major | 3 | D003865 | ClinicalTrials |
| Cardiovascular Diseases | 3 | D002318 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Cholestasis | 3 | D002779 | ClinicalTrials |
| Obesity | 3 | D009765 | ClinicalTrials |
| Intestinal Diseases | 3 | D007410 | ClinicalTrials |
| Cachexia | 3 | D002100 | ClinicalTrials |
| Glomerulonephritis, IGA | 3 | D005922 | ClinicalTrials |
| Anorexia | 3 | D000855 | ClinicalTrials |
| Psychotic Disorders | 2 | D011618 | ClinicalTrials |
| Breast Neoplasms, Male | 2 | D018567 | ClinicalTrials |
| Phobia, Social | 2 | D000072861 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Fatty Liver | 2 | D005234 | ClinicalTrials |
| Inflammation | 2 | D007249 | ClinicalTrials |
| Carcinoma, Lobular | 2 | D018275 | ClinicalTrials |
| Carcinoma, Intraductal, Noninfiltrating | 2 | D002285 | ClinicalTrials |
| Lymphoma, Follicular | 2 | D008224 | ClinicalTrials |
| Schizophrenia | 2 | D012559 | ClinicalTrials |
| Child Development Disorders, Pervasive | 2 | D002659 | ClinicalTrials |
| Asthma | 2 | D001249 | ClinicalTrials |
| Bipolar Disorder | 2 | D001714 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Epilepsy | 2 | D004827 | ClinicalTrials |
| Liver Diseases | 2 | D008107 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 2 | D008180 | ClinicalTrials |
| Non-alcoholic Fatty Liver Disease | 2 | D065626 | ClinicalTrials |
| Renal Insufficiency, Chronic | 2 | D051436 | ClinicalTrials |
| Multiple Sclerosis | 2 | D009103 | ClinicalTrials |
| Substance-Related Disorders | 2 | D019966 | ClinicalTrials |
| Hepatitis C, Chronic | 2 | D019698 | ClinicalTrials |
| Adenoma | 2 | D000236 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Prostatic Neoplasms | 2 | D011471 | ClinicalTrials |
| Brain Concussion | 2 | D001924 | ClinicalTrials |
| Multiple Myeloma | 1 | D009101 | ClinicalTrials |
| Feeding and Eating Disorders | 1 | D001068 | ClinicalTrials |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | D015464 | ClinicalTrials |
| Aging | 1 | D000375 | ClinicalTrials |
| Leukemia | 1 | D007938 | ClinicalTrials |
| Kidney Diseases | 0 | D007674 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 28364 |
| ChEMBL | CHEMBL460026 |
| DrugBank | DB00159 |
| DrugCentral | 3174 |
| EPA CompTox | DTXSID9041023 |
| FDA SRS | AAN7QOV9EA |
| Human Metabolome Database | HMDB0001999 |
| Guide to Pharmacology | 3362 |
| KEGG | C06428 |
| PDB | EPA |
| PharmGKB | PA164746077 |
| SureChEMBL | SCHEMBL20469 |
| ZINC | ZINC000004474603 |